Clinical and Subclinical Keratoconus Cohort Study
1 other identifier
observational
421
1 country
1
Brief Summary
The pathogenesis of keratoconus remains unclear, and its natural course has yet to be fully understood. For non-progressive patients and post-surgical cases, clinical management primarily involves follow-up observation, with significant challenges in visual rehabilitation. This study aims to establish a prospective keratoconus cohort to identify risk factors, natural progression, and the efficacy of interventions. Additionally, it seeks to explore changes in ocular biometric parameters and other pathophysiological characteristics in keratoconus patients, investigate the relationship between keratoconus and systemic diseases or comorbidities, and assess refractive interventions and visual rehabilitation strategies for keratoconus patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2026
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 14, 2026
CompletedFirst Posted
Study publicly available on registry
April 28, 2026
CompletedStudy Start
First participant enrolled
September 1, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2026
Study Completion
Last participant's last visit for all outcomes
December 1, 2029
April 28, 2026
April 1, 2026
Same day
April 14, 2026
April 20, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Kmax
Corneal Topography Pentacam
Baseline, 3 months, 6 months, 1 year, 2 years, 3 years, 4 years, 5 years
Secondary Outcomes (2)
BCVA
Baseline, 3 months, 6 months, 1 year, 2 years, 3 years, 4 years, 5 years
BAD-D
Baseline, 3 months, 6 months, 1 year, 2 years, 3 years, 4 years, 5 years
Other Outcomes (5)
Corneal Endothelial Cell Count
Baseline, 1 year, 2 years, 3 years, 4 years, 5 years
Ocular Biometry Parameters
Baseline, 1 year, 2 years, 3 years, 4 years, 5 years
OCT Imaging Findings
Baseline, 1 year, 2 years, 3 years, 4 years, 5 years
- +2 more other outcomes
Study Arms (1)
keratoconus
keratoconus patient
Eligibility Criteria
subclinical keratoconus and keratoconus
You may qualify if:
- ≤BAD-D \< 2.6 in Pantacam. 1.2 Patients aged 4 years or older. 1.3 informed consent was obtained from patients. If the patient was younger than 18 years of age, the patient and guardian provided written informed consent.
- The contralateral eye was diagnosed with keratoconus, and the included eye met the following criteria: 2.1.1 BCVA≥1.0 2.1.2 No obvious abnormal signs under slit lamp; 2.1.3 BAD-D \< 2.6 in Pantacam. 2.2 Age ≥ 4 years old. 2.3 informed consent was obtained from patients. If the patient was younger than 18 years of age, the patient and guardian provided written informed consent.
- History of myopia and astigmatism, BCVA≤1.0 3.2 Slit-lamp examination reveals at least one sign: corneal thinning, conical protrusion, Vogts striae, Fleischers rings, or anterior stromal scarring.
- abnormal corneal topography features, such as asymmetric bow tie, subtemporal steeping, abnormal thickness distribution, and reduced minimum thickness, with BAD-D≥2.6 in Pantacam.
- Age ≥ 4 years old. 3.5 Informed consent was obtained from patients. If the patient was younger than 18 years of age, the patient and guardian provided written informed consent.
You may not qualify if:
- Patients with a history of ocular surgery and significant corneal scarring.
- Patients who could not understand or cooperate with the examination and follow-up.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Zhongshan Ophthalmic Center, Sun Yat-sen Universitylead
- Hainan Eye Hospitalcollaborator
- The People's Hospital of Ningxiacollaborator
Study Sites (1)
Zhongshan Ophthalmic Center Sun Yat-Sen University
Guangzhou, Guangdong, 510060, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 14, 2026
First Posted
April 28, 2026
Study Start (Estimated)
September 1, 2026
Primary Completion (Estimated)
September 1, 2026
Study Completion (Estimated)
December 1, 2029
Last Updated
April 28, 2026
Record last verified: 2026-04